GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#6)

Company

Addex Therapeutics Ltd.

Filed

August 5, 2024

Accession Number

0001072613-24-000602